Neurology; Internal Medicine; Emergency Medicine; Pathology and Laboratory Medicine
Objective: To assess the time in therapeutic range in patients on warfarin anti-coagulation therapy.
Methods: The retrospective chart review was conducted at Aga Khan University Hospital, Karachi, and comprised data of patients having undergone anti-coagulation with warfarin from January 2013 to April 2015. To determine the mean time in therapeutic range, Rosendaal method was used. Association of time in therapeutic range with the composite outcome, bleeding and thromboembolic events was also assessed. Percentage of patients with time in therapeutic range <60% was calculated.
Results: There were 92 patients whose median time in therapeutic range was 34.9% (interquartile range: 20.0- 55.7). Overall, 71(77.2%) patients had time in therapeutic range below 60% which had statistically significant correlation with the composite outcome (p<0.05). Number of comorbids was significant in predicting time in therapeutic range and patients with time in therapeutic range< 60% (p<0.05).
Conclusion: Subjects had poor anti-coagulation quality. It might be prudent to move towards novel oral anticoagulant drugsas the first choice for therapeutic anti-coagulation.
JPMA. The Journal of the Pakistan Medical Association
Khan, A. Z.,
(2018). Evaluation of quality of warfarin therapy by assessing patient's time in therapeutic range at a tertiary care hospital in Pakistan. JPMA. The Journal of the Pakistan Medical Association, 68(9), 1339-1344.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_med_neurol/187
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.